Module-1 of the ENDCAP-C study showed that their panel of five markers (SFRP2, SFRP4, WIF1, APC1A, and APC2) was accurate in detecting pre-cancerous and invasive neoplasia and dysplasia. The gene discussed is SFRP2; the disease is neoplasm.